Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Novartis
Citi
Moodys
Healthtrust
Federal Trade Commission
Chinese Patent Office
Teva
US Army
Dow
Fuji

Generated: January 18, 2018

DrugPatentWatch Database Preview

Secobarbital sodium - Generic Drug Details

« Back to Dashboard

What are the generic sources for secobarbital sodium and what is the scope of secobarbital sodium patent protection?

Secobarbital sodium
is the generic ingredient in two branded drugs marketed by Anabolic, Barr, Everylife, Halsey, Ivax Pharms, Kv Pharm, Lannett, Parke Davis, Perrigo, Purepac Pharm, Valeant Pharm Intl, Vitarine, Watson Labs, West Ward, Whiteworth Town Plsn, Wyeth Ayerst, Valeant Pharms North, Elkins Sinn, and Lilly, and is included in twenty-three NDAs. Additional information is available in the individual branded drug profile pages.

There is one drug master file entry for secobarbital sodium. One supplier is listed for this compound.
Medical Subject Heading (MeSH) Categories for secobarbital sodium

US Patents and Regulatory Information for secobarbital sodium

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Lilly SECONAL SODIUM secobarbital sodium SUPPOSITORY;RECTAL 086530-004 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Lilly SECONAL SODIUM secobarbital sodium SUPPOSITORY;RECTAL 086530-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Lilly SECONAL SODIUM secobarbital sodium SUPPOSITORY;RECTAL 086530-002 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Vitarine SECOBARBITAL SODIUM secobarbital sodium CAPSULE;ORAL 085898-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Valeant Pharms North SECONAL SODIUM secobarbital sodium CAPSULE;ORAL 086101-001 Oct 3, 1983 RX No Yes ➤ Subscribe ➤ Subscribe ➤ Subscribe
Vitarine SECOBARBITAL SODIUM secobarbital sodium CAPSULE;ORAL 086273-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Everylife SECOBARBITAL SODIUM secobarbital sodium CAPSULE;ORAL 085895-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Wyeth Ayerst SECOBARBITAL SODIUM secobarbital sodium CAPSULE;ORAL 086390-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Valeant Pharms North SECONAL SODIUM secobarbital sodium CAPSULE;ORAL 086101-002 Oct 3, 1983 RX No Yes ➤ Subscribe ➤ Subscribe ➤ Subscribe
Whiteworth Town Plsn SECOBARBITAL SODIUM secobarbital sodium CAPSULE;ORAL 085798-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Baxter
AstraZeneca
Novartis
UBS
Fuji
Farmers Insurance
Argus Health
Express Scripts
Cantor Fitzgerald

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot